These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34296720)

  • 1. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation.
    Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q
    Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ir(III) and Ru(II) Complexes in Photoredox Catalysis and Photodynamic Therapy: A New Paradigm towards Anticancer Applications.
    Raza MK; Noor A; Samantaray PK
    Chembiochem; 2021 Dec; 22(23):3270-3272. PubMed ID: 34558773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
    Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-Acceptor-Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex.
    Wang Z; Wei L; Lin J; Huang C; Chen H; Fan D; Hu W; Liu J; Huang H; Wang Z; Wang X
    J Med Chem; 2024 Aug; 67(15):13435-13445. PubMed ID: 39078925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
    Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-action and Multi-target Ru
    Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer.
    Sanz-Villafruela J; Bermejo-Casadesús C; Riesco-Llach G; Iglesias M; Martínez-Alonso M; Planas M; Feliu L; Espino G; Massaguer A
    Inorg Chem; 2024 Oct; 63(41):19140-19155. PubMed ID: 39361042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
    Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
    J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
    Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
    Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
    Lee SY; Kim CY; Nam TG
    Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
    Jakubaszek M; Goud B; Ferrari S; Gasser G
    Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance.
    Wei L; He X; Zhao D; Kandawa-Shultz M; Shao G; Wang Y
    Eur J Med Chem; 2024 Jan; 264():115985. PubMed ID: 38016298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
    Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
    Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
    Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
    Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
    Mo J; Mai Le NP; Priefer R
    Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
    Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.